Illumina’s Acquisition of GRAIL: A Comparison of the Outcomes
Fordham Law News
NOVEMBER 18, 2022
(“Illumina”), a global genetic testing company, acquired GRAIL LLC (“Grail”), a healthcare start-up that develops early cancer detection tests based on sequencing technologies. [1] 2] With Illumina’s acquisition of Grail, however, the two companies would be reunited “at a critical time.” [3]
52 
Let's personalize your content